 |
| Jul 30 |
| Nutra Pharma wins patent for antiviral treatment using cobra venom patent | |
| Jul 30, 2010 (Datamonitor via COMTEX) --Nutra Pharma, a biotechnology company, has received approval from the US Patent and Trademark Office for its patent describing a method of treating and preventing infectious diseases, including colds, flu viruses, and bacterial and parasitic infections, using modified and detoxified cobra venom and neurotoxins.The new patent describes a method for treating More... |
|
|
| Jul 29 |
| Abbott wins FDA approval for new dosage strengths of cholesterol drug fda approval | |
| Jul 29, 2010 (Datamonitor via COMTEX) --Abbott, a health care company, has received FDA approval for two new dosage strengths of Simcor, a cholesterol medication.The new Simcor dosage strengths combine 40mg of simvastatin, the most commonly prescribed dose of simvastatin, with either 500mg or 1,000mg of niacin extended-release. More... |
|
|
| Jul 29 |
| A5 Laboratories files patent application for interferon production patent | |
| Jul 29, 2010 (Datamonitor via COMTEX) --A5 Laboratories, a contract research based organization, has submitted a provisional patent application to protect its technology for the production of interferon-based products.According to the company, the patent application describes the company's new method for producing therapeutic proteins as well as specifically providing details of the production of company's More... |
|
|
| Jul 29 |
| ONE Bio Obtains New Extraction Technology Patent patent | |
| The new Salvia Miltiorrhiza extract is expected to contribute approximately $2.2 million to the Company's revenue for the remaining of this year with several placed orders pending delivery. The extract is expected to boost the Company's CHE division revenues which has already gained co-operative contracts with multiple renowned pharmaceuticals including Heji Huangpu Baiyunshan Pharmaceutical, Beijing Tongrentang Pharmaceutical, Guangdong Medihealth Pharmaceutical and Jiangmen Mingsheng More... |
|
|
| Jul 28 |
| Nutra Pharma Receives Patent for Novel Antiviral Treatment Using Modified Cobra Venom patent | |
| CORAL SPRINGS, FL -- (MARKET WIRE) -- 07/28/10 --Nutra Pharma Corporation (OTCBB: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), Human Immunodeficiency Virus (HIV), Multiple Sclerosis (MS) and Pain, announced today that it has received approval from the United States Patent and Trademark Office (USPTO) for its More... |
|
|
|
|
|
